GPC1 and cancer: There is compelling evidence that Glypican-1 (GPC-1), a cell surface antigen overexpressed in various solid tumors but largely absent in normal tissues, plays a key role in the progression of cancers such as prostate, pancreatic, bladder, gastroesophageal, ovarian, and GBM [106,107,108,109,110].